EP3889173
OPTIMIZED FACTOR VIII GENE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.2.2014EP published:
5.7.2023EP application number:
20204866.6
EPO information:
European Patent Register
Max expiry date:
13.2.2034
Title in English:
OPTIMIZED FACTOR VIII GENELanguage of the patent:
English
Timeline
Today
14.2.2014EP application
5.7.2023EP Publication
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham MA 02451, US
Inventor
Name:
TAN, SiyuanAddress:
Lexington, MA 02421, US
Name:
PETERS, Robert, T.Address:
Needham, MA 02492, US
Priority
Number:
201361765626 PDate:
15.2.2013Country:
US
Classification
Categories:
C07K 14/755